HHHany Mohamed El Hennawy

Hany Mohamed El Hennawy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hany Mohamed El Hennawy has a total of 202 co-authors. Here are the top co-authors by number of shared publications:

  • Omar Safar

    Urology Department, Armed Forces Hospitals, Khamis Mushayte, Saudi Arabia

    26 shared publications
  • Abdullah S. Al Faifi

    Surgery Department, Section of Transplantation, Armed Forces Hospitals, Khamis Mushayte, Saudi Arabia

    19 shared publications
  • Mohammad F. Zaitoun

    Pharmacy Department, Pharmaceutical Care, Diaverum Saudi Arabia, Riyadh, Saudi Arabia

    17 shared publications
  • Ahmed Mahedy

    Nephrology Department, Armed Forces Hospitals Southern Region, Khamis Mushayte, Saudi Arabia

    11 shared publications
  • Eisa Al Atta

    Surgery Department, Section of Transplantation, Armed Forces Hospitals Southern Region, Khamis Mushayte, Saudi Arabia

    11 shared publications
  • Weam El Nazer

    Nephrology Department, Armed Forces Hospitals, Southern Region, Khamis Mushayte, Saudi Arabia

    9 shared publications

Latest Publications

  • Bladder Management in Pediatric Kidney Transplantation: A Narrative Systematic Review With a Hypothesis‐Generating Phenotype Framework

    by Hany M. El Hennawy, Ghaleb Aboalsamh, Osama Shalkamy, Mahmoud Z. Madawie, Fadil Hassan, Tarek M. Jaber, Ramiz A. Aesh, Abdulaziz A. Albalawi, Abdulla Alharthi, Turki A. Banamah, et al.

    Congenital anomalies of the kidney and urinary tract cause 30%–50% of pediatric end‐stage renal disease, and roughly one‐third of affected children have clinically significant lower urinary tract dysfunction (LUTD). Transplanting into a dysfunctional bladder increases the risks of infection, graft pyelonephritis, and graft loss; however, there is no consensus on clinical objectives, catheterization and augmentation practices vary across centers, and no validated bladder‐specific risk score has been established. Following PRISMA 2020, we searched PubMed, Embase, and the Cochrane Library (2000–2025) for studies of pediatric kidney transplant recipients (≤ 18 years) that reported graft, urologic, or infectious outcomes related to bladder function. Two reviewers screened studies and extracted data, and risk of bias was assessed with the Newcastle‐Ottawa Scale. Fifty‐two studies met the inclusion criteria, including 10 retrospective cohort studies with 428 children. Because comparable cohorts were few and outcome definitions were heterogeneous, the evidence was synthesized narratively, with quantitative pooling limited to graft survival in five cohorts. Pooled graft survival in recipients with LUTD was 83.8% (95% CI 75.6%–89.7%; I 2 = 28%; moderate certainty), and the available comparisons showed no significant difference in graft survival between recipients with LUTD and those with normal bladders. Urologic complication and urinary tract infection (UTI) rates varied primarily with follow‐up duration rather than with underlying pathology alone. Seven risk factors were associated with adverse outcomes; children with three or more factors had higher UTI rates and lower 5‐year graft survival than those with fewer factors. Clean intermittent catheterization and Mitrofanoff procedures were associated with better long‐term graft survival despite higher UTI rates. We propose classifying LUTD into four phenotypes according to the dominant injury mechanism: low compliance with high pressure, poor emptying, isolated detrusor overactivity, and mixed dysfunction. This framework is hypothesis‐generating and requires prospective validation. Overall certainty of evidence is low to moderate; consensus definitions, registry harmonization, and prospective validation of phenotype‐based algorithms should take priority over the publication of further unvalidated risk scores. Trial Registration: PROSPERO: CRD420261416509

  • Open Access

    Cytomegalovirus and BK polyomavirus in belatacept-treated kidney transplant recipients: a systematic review and meta-analysis

    by Ibrahim Tawhari, Fatma Yamani, Manal Alotaibi, Hany El Hennawy, Mohammed Tawhari, Muath Alqahtani, Khalid Asiri

    This systematic review and meta-analysis evaluated the risk of cytomegalovirus (CMV) and BK virus infections in kidney transplant recipients receiving belatacept-based immunosuppression compared to calcineurin inhibitor (CNI)-based regimens. Seven studies (six randomized controlled trials and one cohort study) involving 1,625 patients were analyzed. Pooled results showed little to no evidence of a difference in CMV infection risk between belatacept and CNI-treated patients (odds ratio [OR] 1.24, 95% confidence interval [CI] 0.80-1.94; P = 0.34). However, there was little to no evidence of a difference in BK virus infection risk, though the point estimate suggested a possible increase (OR 2.11, 95% CI 0.71-6.33, P = 0.18). Heterogeneity was low across studies (I² = 0%). A sensitivity analysis excluding the single non-randomized cohort study (i.e., restricted to the randomized controlled trials) showed little to no evidence of a difference in CMV infection risk (OR 1.16, 95% CI 0.57-2.37; P = 0.69). While belatacept offers renal and metabolic advantages over CNIs, the potential for CMV and BK viremia necessitates careful monitoring, particularly in high-risk patients. Standardized viral surveillance and further research in larger cohorts are needed to clarify long-term infection risks.

  • Preventive Dental Strategies to Minimize Oral Health Complications After Renal Transplantation: A Systematic Review

    by Hany M. El Hennawy, Maryam H. El Hennawy, Omar Safar, Tariq M Jaber, Ghaleb A Aboalsamh, Muhammed Awais, Ibrahim Tawahri, Mohamed E. Balla, Abdullah H. Almalki

  • The Economic Imperative of Living Donor Kidney Transplantation: A Single-Center Micro-Cost Analysis for Sustainable ESRD Care in Saudi Arabia

    by Hany M. El Hennawy, Nashat Al Otaibi, Eman Kotbi, Rawan Al Zahrani, Ghiada Al Maghrabi, Omar Safar, Tariq Jaber, Menna El Hennawy, Abdullah Khedr, Mona Ibrahim, et al.

  • Risk Factors and Outcomes of Bowel Complications in Single-Site Donor Nephrectomy: A Retrospective Analysis of 350 Consecutive Cases

    by Hany M El Hennawy, Omar Safar, Ghaleb Aboalsamh, Menna El Hennawy, Abdullah Khedr, Mona Ibrahim, Ibrahim Tawahri, Osama Shalkamy, Mahmoud Z El Madaawi, Tariq Jaber

    This study evaluated the incidence, risk factors, and management of bowel complications in a consecutive series of laparoendoscopic single -site donor nephrectomy procedures. A retrospective analysis was performed on 350 consecutive laparoendoscopic single -site donor nephrectomy cases (68 % male donors ; mean age 31.5 ± 8.2 years; mean body mass index 26.1 ± 4.8 ; 8.6 % with prior abdominal surgery ) seen from September 2017 through July 2025 at a high -volume center. The bowel complication rate was 1.14 % (4 of 350 ). Etiologies included internal herniation (n = 1 ), adhesive obstruction (n = 1 ), obstruction postserosal repair (n = 1 ), and bowel perforation (n = 1 ). All cases required surgical management, including 3 bowel resections and 1 laparoscopic defect closure. The 4 affected donors had a higher mean age (40.1 ±3.9 years ) and mean body mass index (33.7 ± 1.9 ), and 50 % had received prior abdominal surgery, both of which significantly exceeded the cohort baseline. No complications stemmed from initial port insertion or thermal injury. The overall 30 -day readmission rate was 2.28 %, and the recipient 1 -year graft survival rate was 97.3 %. Bowel complications following laparoendoscopic single -site donor nephrectomy are rare but clinically significant, predominantly presenting postoperatively and requiring surgical intervention. High body mass index and a history of abdominal surgery are key associated risk factors. Meticulous surgical technique remains paramount to minimize risk. Therefore, meticulous surgical technique and careful patient selection, particularly in donors with obesity or prior abdominal surgery, are more critical to bowel safety than the choice of a minimally invasive approach.

  • Incisional hernia after kidney transplantation: a systematic review and proposal of a peri-transplant risk scoring system for tailored preventive surgical planning

    by Hany M. El Hennawy, Omar Safar, Ghaleb A. Aboalsamh, Salahadin Lamy, Abdullah H. Almalki, Laila F. Sadagah, Ibrahim Tawahri, Ahmed Nasr Shazly, Tariq M. Jaber

  • Optimizing Renal Allograft Dysfunction Management: A Systematic Review and Proposed Algorithm for Interventional Radiology Versus Surgical Interventions

    by Hany M. El Hennawy, Omar Safar, Ghaleb A Aboalsamh, Ibrahim Tawahri, Abdullah H. Almalki, Tariq M Jaber, Mohamed F. Bazeed, Tayseer Mohammed Ghalyoob, Ahmed Nasr Shazly, Ahmed El Hadad, et al.

  • The Simplified Pregnancy Risk Score (SPRS): Personalized Preeclampsia Risk Stratification for Living Kidney Donors

    by Hany M El Hennawy, Omar Safar, Ghaleb Aboelsamh, Laila Fahad Sadagah, Menna El Hennawy, Mohamed Elamien Balla, Abdullah Khedr, Mona Ibrahim, Tariq Jaber, Ibrahim Tawahri

    Pregnancy after living kidney donation is associated with increased risk of preeclampsia and other hypertensive disorders; however, clinical practice and a standardized approach remain unclear. We performed a systematic review and meta-analysis to provide updated risk estimates for adverse pregnancy outcomes after living kidney donation, to allow development and preliminary assessment of the Simplified Pregnancy Risk Score, a structured framework for individualized risk stratification. We followed PRISMA guidelines and searched PubMed, Scopus, Web of Science, and the Cochrane Library through August 2023 to include studies on maternal and fetal outcomes in pregnancies after living kidney donation. We used random-effects models to pool odds ratios and calculate absolute risk differences. We used subgroup and regression analyses to identify key risk modifiers that informed the development of the points-based Simplified Pregnancy Risk Score. Our search identified 15 studies encompassing 4200 pregnancies. Preeclampsia (pooled incidence 7.2%; odds ratio = 2.86; 95% CI, 1.62-5.05; absolute risk difference +4.7% ) and gestational hypertension (odds ratio = 2.53, 95% CI, 1.11-5.74)were significantly increased in donors compared with nondonors. Risk of preterm birth was modestly increased (odds ratio = 1.32; 95% CI, 1.01-1.74). Subgroup analyses identified clinically relevant effect modifiers: donors aged ≥35 years had higher odds of preeclampsia than younger donors, and a donation-to-conception interval of <2 years was associated with increased risk of preterm birth. The Simplified Pregnancy Risk Score integrated 8 evidence-based factors into a simple points-based system, categorizing donors as low (0-2 points), moderate (3-5 points), or high risk (≥6 points). The Simplified Pregnancy Risk Score represents the first structured, evidence-informed framework designed to support individualized pre-conception counseling and risk-aware antenatal management in kidney donors. Although formal validation is required, this system addresses a critical translational gap by converting population-level evidence into actionable clinical risk stratification.

  • Kidney Transplantation as Curative Therapy for Refractory Dialysis-induced Hypotension: A Case Report and Literature Review

    by Hany El Hennawy, Hassan Yousef, Atheer Al Qahtani, Eisa Al Atta, Mazin A. Sarhan, Mohamed Attia, Mohammad F. Zaitoun, Omar Safar, Mofareh M. Alqahtani, Ahmed Mahedy

  • Contained Colonic Perforation Following Sclerotherapy and Laparoscopic Fenestration for a Post-Transplant Lymphocele: A Case Report and Review

    by Hany El Hennawy, Fadil Hassan, Ramiz Ahmed Aesh, Laila F. Sadagah, Eman Kotbi, Omar Safar, Ghaleb A. Aboalsamh, Abdullah H. Almalki, Menna El Hennawy, Abdulla Ahmed Kheder, et al.